Article info
PDFConcise report
Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation
- Correspondence to:
Mirjam K de Vries
MD, VU University Medical Centre, Rheumatology department, room 4A-42, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; mk.devries{at}vumc.nl
Citation
Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation
Publication history
- Accepted April 19, 2007
- First published May 1, 2007.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by Annals of the Rheumatic Diseases